Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
TempraMed TechnologiesFRA:9DY -4.62%12 Days Inventory is 197.94 as of Mar. 2026, which is 234% above its 10-year median of 59.27. GuruFocus rates FRA:9DY with a GF Score™ of 12/100. The stock has 5 warning signs investors should review. Among 787 Medical Devices & Instruments companies, TempraMed Technologies ranks worse than 75.86% on this metric.
The historical rank and industry rank for TempraMed Technologies's Days Inventory or its related term are showing as below:
FRA:9DY'
s Days Inventory Range Over the Past 10 Years
Min: 34.56 Med: 59.27 Max: 289.05
Current: 289.05
During the past 3 years, TempraMed Technologies's highest Days Inventory was 289.05. The lowest was 34.56. And the median was 59.27.
FRA:9DY's Days Inventory is ranked worse than 75.86% of 787
companies
in the Medical Devices & Instruments industry
Industry Median: 179.47
vs FRA:9DY: 289.05
If a company builds up inventory, it may mean it is having difficulties selling its goods.
Inventory Turnover measures how fast the company turns over its inventory within a year.
TempraMed Technologies's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.46.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
TempraMed Technologies's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 1.23.
TempraMed Technologies (FRA:9DY) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
TempraMed Technologies's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
TempraMed Technologies's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
TempraMed Technologies Days Inventory Related Terms
TempraMed Technologies Days Inventory Historical Data
* Premium members only.
The historical data trend for TempraMed Technologies's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:9DY vs ABT, SYK, MDT: Days Inventory Comparison
For the Medical Devices subindustry, TempraMed Technologies's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
TempraMed Technologies Days Inventory vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, TempraMed Technologies's Days Inventory distribution charts can be found below:
* The bar in red indicates where TempraMed Technologies's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TempraMed Technologies (FRA:9DY) has a Days Inventory of 197.94 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on TempraMed Technologies and its competitors. This is 234% above median its historical median of 59.27. Over the past decade, TempraMed Technologies' Days Inventory has ranged from 34.56 to 289.05. According to the industry distribution chart, TempraMed Technologies ranks #597 out of 787 companies in the Medical Devices & Instruments industry, placing it in the top 75.9%.
Is TempraMed Technologies' Days Inventory too high?
TempraMed Technologies' current Days Inventory of 197.94 is 234% above median its 10-year median of 59.27. Over the past 10 years, this metric has ranged from a low of 34.56 to a high of 289.05. The Medical Devices & Instruments industry median Days Inventory is 179.47. TempraMed Technologies' value of 197.94 is 10.3% above this industry median. Based on the distribution chart, TempraMed Technologies ranks #597 out of 787 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, TempraMed Technologies has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does TempraMed Technologies' Days Inventory compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, TempraMed Technologies ranks #597 out of 787 companies for Days Inventory. This places TempraMed Technologies in the lower half of its industry. The industry median Days Inventory is 179.47. TempraMed Technologies' value of 197.94 is 10.3% above this benchmark. Historically, TempraMed Technologies' own Days Inventory has ranged from 34.56 to 289.05 over the past decade. While the company's 10-year median is 59.27 vs. the industry median of 179.47, TempraMed Technologies has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Medical Devices & Instruments company?
The median Days Inventory among Medical Devices & Instruments companies is 179.47, based on 787 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. TempraMed Technologies's current Days Inventory of 197.94 is 10.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on TempraMed Technologies and its competitors. For the Medical Devices & Instruments industry, the median Days Inventory is 179.47 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. TempraMed Technologies's current Days Inventory is 197.94, which is 234% above median its own 10-year median of 59.27. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TempraMed Technologies stock overvalued right now?
TempraMed Technologies (FRA:9DY) has a current Days Inventory of 197.94. The current Days Inventory is 197.94, which is 234% above median its 10-year median of 59.27 and 10.3% above the Medical Devices & Instruments industry median of 179.47. TempraMed Technologies' overall GF Score™ is 12/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For TempraMed Technologies (FRA:9DY), the current Days Inventory is 197.94 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
TempraMed Technologies Ltd through its subsidiary, engaged in developing patent-protected technology designed to serve a broad range of medical and consumer products. TempraMed's primary focus is revolutionizing storage and management of injectable for temperature-sensitive medications. This inventive technology ensures adequate temperature storage conditions to medications without requiring power source or human intervention for years.
12GF Score
Get the complete analysis for FRA:9DY
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:9DY has been successfully added to your 
